Showing results (1151-1160 of 1,278) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|October 27, 2006
Brief report: paroxetine in younger and adult individuals at high risk for suicideMark S Bauer, Stephen R Wisniewski, Jane N Kogan, et al.Psychopharmacology Bulletin|October 17, 2003
New approaches to modeling bipolar disorderHaim Einat, Robert H Belmaker, Husseini K ManjiPsychopharmacology Bulletin|November 11, 2003
Evidence-based decision-making in psychopharmacologyRanga KrishnanPsychopharmacology Bulletin|November 11, 2003
Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot studyPatricia K Corey-Lisle, Howard Birnbaum, Paul Greenberg, et al.Psychopharmacology Bulletin|August 1, 2008
Bipolar-I depression outpatient treatment quality and costs in usual care practiceAlisa B Busch, Richard G Frank, Gary SachsPsychopharmacology Bulletin|September 10, 2008
Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesiaArija Maat, Annemarie Fouwels, Lieuwe de HaanPsychopharmacology Bulletin|September 10, 2008
Psychometric evaluation of a patient-rated troubling symptom scale for generalized anxiety disorder clinical trialsGahan J Pandina, Dennis A Revicki, Leah Kleinman, et al.Psychopharmacology Bulletin|May 2, 2018
A Case of Concomitant Pseudocyesis and Couvade Syndrome VariantSrinagesh Mannekote Thippaiah, Vinu George, Badari Birur, et al.Psychopharmacology Bulletin|June 20, 2017
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and SafetyMatthew T Morris, Sandip P TarpadaPsychopharmacology Bulletin|January 1, 1991
Discrepancies between patient report, clinical assessment, and urine analysis in psychiatric patients during inpatient admissionJ N Wilkins, A L Shaner, M Patterson, et al.Pageof 128